Changeflow GovPing Pharma & Drug Safety Glutamic Acid Decarboxylase Patent Publication ...
Routine Notice Added Final

Glutamic Acid Decarboxylase Patent Publication EP2026028978A1

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office (EPO) has published patent application EP2026028978A1 concerning Glutamic Acid Decarboxylase and its applications. The publication date is March 18, 2026. The application is classified under various International Patent Classification (IPC) codes related to biotechnology and food science.

What changed

The European Patent Office (EPO) has published patent application EP2026028978A1, titled 'Glutamic Acid Decarboxylase and Application Thereof'. The publication date is March 18, 2026. The application covers various aspects related to glutamic acid decarboxylase, including its use in food products and its genetic manipulation, as indicated by the IPC classifications.

This publication represents the grant of a patent application, not a new regulatory requirement for companies. Compliance officers should note this for intellectual property tracking related to biotechnology and pharmaceutical research, particularly for entities operating within or seeking patents in the designated European states. No immediate compliance actions are required.

Source document (simplified)

← EPO Patent Bulletin

GLUTAMIC ACID DECARBOXYLASE AND APPLICATION THEREOF

Publication EP2026028978A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 9/88 20060101AFI20260207BHEP A23L 33/12 20160101ALI20260207BHEP C12N 1/15 20060101ALI20260207BHEP C12N 1/19 20060101ALI20260207BHEP C12N 1/21 20060101ALI20260207BHEP C12N 5/10 20060101ALI20260207BHEP C12N 15/60 20060101ALI20260207BHEP C12N 15/63 20060101ALI20260207BHEP C12P 7/52 20060101ALI20260207BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

GLUTAMIC ACID DECARBOXYLASE AND APPLICATION THEREOF

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026028978A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Labeling
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.